Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Metastatic to Brain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05465343
What this trial is testing

Furmonertinib in EGFR-Mutant NSCLC With Brain Metastases (iFORCE)

Who this might be right for
FurmonertinibEGFR-mutationNSCLC+1 more
Peking Union Medical College 24
Not applicableStudy completedNCT00007007
What this trial is testing

Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases

Who this might be right for
Cognitive/Functional EffectsMetastatic CancerRadiation Toxicity
Radiation Therapy Oncology Group 59
Early research (Phase 1)Not Yet RecruitingNCT07674693
What this trial is testing

Phase 1 Study of WBRT or PCSI With REYOBIQ for Leptomeningeal Metastases

Who this might be right for
Leptomeningeal Metastases
NYU Langone Health 29
Not applicableEnded earlyNCT02269111
What this trial is testing

Quantitative MRI in Assessing Disease in Patients With Brain Tumors

Who this might be right for
Tumors Metastatic to BrainUnspecified Adult Solid Tumor, Protocol Specific
Vanderbilt-Ingram Cancer Center 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT06777433
What this trial is testing

Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases

Who this might be right for
Brain Metastases From Solid Tumors
Radiopharm Theranostics, Ltd 30
Not applicableStudy completedNCT04281784
What this trial is testing

Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)

Who this might be right for
DementiaChronic DiseaseNeoplasm Metastasis+8 more
University of Washington 2,512
Testing effectiveness (Phase 2)Study completedNCT00005952
What this trial is testing

Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorHead and Neck Cancer+5 more
Duke University 30
Not applicableNot Yet RecruitingNCT07638709
What this trial is testing

Impact of Radiotherapy-Immunotherapy Timing in NSCLC Brain Metastases

Who this might be right for
Non Small Cell LungBrain Metastasases
Xiangya Hospital of Central South University 150
Testing effectiveness (Phase 2)WithdrawnNCT03803761
What this trial is testing

A New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Malignant Neoplasm in the Brain+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT03608020
What this trial is testing

A Trial for Treatment of Cancer Patients With Multiple Brain Metastases Undergoing Whole-Brain Radiotherapy

Who this might be right for
Multiple Brain Metastases
BioMimetix JV, LLC 35
Post-approval studies (Phase 4)Study completedNCT02052024
What this trial is testing

Myobloc Atrophy Study

Who this might be right for
Spasticity Secondary to Either a Disorder or TraumaSpinal Cord Injury (SCI)Brain Injury+2 more
Georgetown University 10
Testing effectiveness (Phase 2)UnknownNCT04303988
What this trial is testing

A Phase II Study of Triple-negative Breast Cancer Brain Metastases.

Who this might be right for
Breast Cancer
Fudan University 35
Large-scale testing (Phase 3)UnknownNCT00268684
What this trial is testing

Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell LungNeoplasm Metastasis
Tel-Aviv Sourasky Medical Center 381
Early research (Phase 1)Ended earlyNCT00253721
What this trial is testing

Melphalan With BBBD in Treating Patients With Brain Malignancies

Who this might be right for
Brain and Central Nervous System TumorsLymphomaMetastatic Cancer
OHSU Knight Cancer Institute 21
Testing effectiveness (Phase 2)Study completedNCT01015534
What this trial is testing

Whole Brain Radiotherapy With or Without Temozolomide at Daily Fixed-dose for Brain Metastases Treatment

Who this might be right for
Brain Neoplasms
Instituto Nacional de Cancerologia de Mexico 55
Testing effectiveness (Phase 2)Looking for participantsNCT06945705
What this trial is testing

A Clinical Trial of Furmonertinib Combined With Anlotinib as First-line Treatment for Advanced NSCLC With EGFR-sensitive Mutations and Brain Metastasis

Who this might be right for
NSCLC
Henan Cancer Hospital 146
Testing effectiveness (Phase 2)UnknownNCT00009854
What this trial is testing

Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm

Who this might be right for
Brain and Central Nervous System TumorsMetastatic Cancer
Direct Therapeutics
Very early researchLooking for participantsNCT06328686
What this trial is testing

Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic Malignant Solid Neoplasm
Emory University 10
Not applicableLooking for participantsNCT04833335
What this trial is testing

ASL in Brain Metastasis MRI Following Gamma Knife Treatment

Who this might be right for
Brain Metastases
Assistance Publique - Hôpitaux de Paris 60
Testing effectiveness (Phase 2)UnknownNCT01130779
What this trial is testing

The Continuation of Erlotinib

Who this might be right for
Non-small Cell Lung Cancer
Samsung Medical Center 23
Next Page